Status:
UNKNOWN
Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas
Lead Sponsor:
Karolinska Institutet
Conditions:
Contrast Media
Computed Tomography
Eligibility:
All Genders
50+ years
Brief Summary
To examine inter-subject variations of optimal late arterial phase contrast-enhancement defined as the greatest difference in contrast attenuation of hepatocellular carcinoma (HCC) compared to backgro...
Detailed Description
Background: Many previous studies have analyzed and proposed different strategies to achieve optimal contrast timing and enhancement in the late arterial phase to best depict arterialized lesions in t...
Eligibility Criteria
Inclusion
- patients, who are scheduled for a multiphasic liver or pancreas CT because of known or suspected malignancy in the liver or pancreas.
Exclusion
- below 50 years of age, contrast media allergy or decreased kidney function
Key Trial Info
Start Date :
September 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04813432
Start Date
September 10 2018
End Date
May 1 2021
Last Update
March 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radiology Department, Karolinska Huddinge university hospital
Stockholm, Sweden, 14186